This page shows the latest hVIVO news and features for those working in and with pharma, biotech and healthcare.
The study will be sponsored by Imperial College London and conducted by hVIVO at The Royal Free Hospital’s specialist research unit in London. ... The government has already secured the first three slots to test vaccine using the challenge study, which
UK BIOTECH. Universal flu vaccine shows promise in phase 2. UK next-generation vaccines company hVIVO has unveiled promising results for its universal flu vaccine candidate. ... FLU-v is being developed by Imutex, hVIVO's 49% joint venture with PepTcell
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...